KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Receivables - Other: 2010-2024

Historic Receivables - Other for Chemed (CHE) over the last 11 years, with FY2024 value amounting to $8.8 million.

  • Chemed's Receivables - Other rose 37529.21% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 37529.21%. This contributed to the annual value of $8.8 million for FY2024, which is 42850.27% up from last year.
  • Per Chemed's latest filing, its Receivables - Other stood at $8.8 million for FY2024, which was up 42850.27% from $1.7 million recorded in FY2023.
  • Over the past 5 years, Chemed's Receivables - Other peaked at $8.8 million during FY2024, and registered a low of $1.7 million during FY2023.
  • Over the past 4 years, Chemed's median Receivables - Other value was $1.9 million (recorded in 2021), while the average stood at $3.5 million.
  • In the last 5 years, Chemed's Receivables - Other plummeted by 892.66% in 2023 and then skyrocketed by 42850.27% in 2024.
  • Chemed's Receivables - Other (Annual) stood at $1.9 million in 2021, then fell by 3.59% to $1.8 million in 2022, then fell by 8.93% to $1.7 million in 2023, then skyrocketed by 428.5% to $8.8 million in 2024.
  • Its Receivables - Other was $8.8 million in FY2024, compared to $1.7 million in FY2023 and $1.8 million in FY2022.